Company
Leadership
Ethics & Compliance
Products
Infasurf®
AerVia
Pipeline
Research
News
Careers
Contact
News
All
Community
Company
Corporate Responsibility
Culture
Product Development
Jun 16, 2025
AerVia® Neonatal Supraglottic Airway: Now Commercially Available
ONY Biotech is pleased to announce the commercial availability of AerVia®, the first and only supraglottic airway device specifically designed for neo...
Apr 24, 2025
Introducing AerVia® Neonatal Supraglottic Airway
We are proud to announce the launch of AerVia®, a next generation supraglottic airway device designed specifically for neonates. Whether in the delive...
Feb 17, 2025
First Patient Enrolled in Aero-05 Study: Evaluating InfasurfAero™ for Non-Invasive Surfactant Delivery in Preterm Newborns
ONY Biotech is excited to announce that the first patient has been enrolled in the Aero-05 clinical study, marking a significant milestone in the eval...
Aug 27, 2024
ONY Biotech: Settling in and Planning the Next Phases of Our Expansion
With our corporate offices now fully operational at 455 Commerce Drive, we are excited to share some highlights from our new workspace and outline the...
Jun 24, 2024
Staying Connected: ONY Biotech’s Upgrade to Enhance Facility Monitoring
Modern technology has placed the world at everyone’s fingertips. Whether through cell phones, laptops, or smartwatches, we can connect with the online...
Mar 11, 2024
Our Next Chapter: ONY Biotech Acquires New Building
Change is on the horizon for ONY Biotech, and we couldn’t be more thrilled to share the exciting news with you. After more than three decades of...
Feb 23, 2024
An Opportunity for Medical Advancement: ONY Biotech’s Investigator-Initiated Research Program
At ONY Biotech, innovation is not just a buzzword; it’s a commitment woven into every breath we take. We are excited to announce our Investigato...
Nov 1, 2023
The Power of Teamwork: Achieving a Record-High Sales Month
We are thrilled to announce that ONY Biotech has achieved record-breaking international sales in August 2023, resulting in an all-time high month of r...
Oct 2, 2023
Illuminating the Path Forward
“Prematurity accounts for most newborn deaths, and most of these deaths could be prevented with currently available, cost-effective interventions.” – ...
Jul 26, 2023
Post-hoc Analysis of AERO-02 Trial Completed
Analysis results are in: nebulized calfactant reduced the need for instilled liquid surfactant by 50% in infants with clinical RDS born at 28-36 weeks...
Jul 6, 2023
Over At ONY Biotech: Our Focus on Workplace Wellness
#OverAtONYBiotech, we understand that the strength of our company relies on the well-being and satisfaction of our employees. Workplace wellness is an...
May 30, 2023
Big Moves at ONY Biotech
At ONY Biotech, we are guided by our 4 core values: persistence, passion, positivity, and professionalism. Every department exemplifies these values, ...
Oct 21, 2022
Honoring ONY’s founder, Dr. Edmund Egan
Earlier this year, our founder and longtime Chief Medical Officer, Dr. Edmund Egan—known by many as Ted—announced his retirement after more than 37 ye...
Nov 3, 2020
Study Results are in on a Potential Non-Invasive Treatment for RDS
Study Results are in on a Potential Non-Invasive Treatment for RDS, the Leading Cause of Death in Premature Babies Has the potential to reduce intubat...
May 19, 2020
ONY Biotech Prepares for the Future
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buf...
Mar 18, 2020
Infasurf® (calfactant) Business Continuity Statement: COVID-19
To Our Customers, It has become clear in the past few weeks we are facing an unprecedented challenge whose impact is being felt worldwide. We recogniz...
May 13, 2019
ONY Cares for Kids Too
On May 9th, 2019, local radio stations Kiss 98.5 and WBEN hosted the annual Kiss Cares for Kids/ WBEN Radiothon to benefit Oishei Children’s Hospital....
Feb 26, 2019
Leading the Way in Neonatal Therapies
Buffalo Business First speaks to ONY Biotech about the company’s continued strides toward creating innovative therapies to improve outcomes for ...
Jun 28, 2018
Just Chillin’
Summer is in full swing here in Buffalo and wherever there is hot weather, ice cream is not far behind. While we work hard day in and day out at ONY B...
May 12, 2018
Walking Among Super Heroes
To commemorate Women and Children’s Hospital’s big move last year, local radio station Kiss 98.5 hosted the first annual Super Hero Walk. The walk mir...
Oct 16, 2017
We like to move it, move it.
Moving a hospital is a huge undertaking, encompassing hundreds of hours of planning to help make sure every patient transition is smooth all while kee...
May 13, 2019
ONY Cares for Kids Too
On May 9th, 2019, local radio stations Kiss 98.5 and WBEN hosted the annual Kiss Cares for Kids/ WBEN Radiothon to benefit Oishei Children’s Hospital....
May 12, 2018
Walking Among Super Heroes
To commemorate Women and Children’s Hospital’s big move last year, local radio station Kiss 98.5 hosted the first annual Super Hero Walk. The walk mir...
Oct 16, 2017
We like to move it, move it.
Moving a hospital is a huge undertaking, encompassing hundreds of hours of planning to help make sure every patient transition is smooth all while kee...
Jun 16, 2025
AerVia® Neonatal Supraglottic Airway: Now Commercially Available
ONY Biotech is pleased to announce the commercial availability of AerVia®, the first and only supraglottic airway device specifically designed for neo...
Apr 24, 2025
Introducing AerVia® Neonatal Supraglottic Airway
We are proud to announce the launch of AerVia®, a next generation supraglottic airway device designed specifically for neonates. Whether in the delive...
Feb 17, 2025
First Patient Enrolled in Aero-05 Study: Evaluating InfasurfAero™ for Non-Invasive Surfactant Delivery in Preterm Newborns
ONY Biotech is excited to announce that the first patient has been enrolled in the Aero-05 clinical study, marking a significant milestone in the eval...
Aug 27, 2024
ONY Biotech: Settling in and Planning the Next Phases of Our Expansion
With our corporate offices now fully operational at 455 Commerce Drive, we are excited to share some highlights from our new workspace and outline the...
Jun 24, 2024
Staying Connected: ONY Biotech’s Upgrade to Enhance Facility Monitoring
Modern technology has placed the world at everyone’s fingertips. Whether through cell phones, laptops, or smartwatches, we can connect with the online...
Mar 11, 2024
Our Next Chapter: ONY Biotech Acquires New Building
Change is on the horizon for ONY Biotech, and we couldn’t be more thrilled to share the exciting news with you. After more than three decades of...
Feb 23, 2024
An Opportunity for Medical Advancement: ONY Biotech’s Investigator-Initiated Research Program
At ONY Biotech, innovation is not just a buzzword; it’s a commitment woven into every breath we take. We are excited to announce our Investigato...
Nov 1, 2023
The Power of Teamwork: Achieving a Record-High Sales Month
We are thrilled to announce that ONY Biotech has achieved record-breaking international sales in August 2023, resulting in an all-time high month of r...
May 30, 2023
Big Moves at ONY Biotech
At ONY Biotech, we are guided by our 4 core values: persistence, passion, positivity, and professionalism. Every department exemplifies these values, ...
Oct 21, 2022
Honoring ONY’s founder, Dr. Edmund Egan
Earlier this year, our founder and longtime Chief Medical Officer, Dr. Edmund Egan—known by many as Ted—announced his retirement after more than 37 ye...
May 19, 2020
ONY Biotech Prepares for the Future
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started working at the Children’s Hospital of Buf...
Oct 2, 2023
Illuminating the Path Forward
“Prematurity accounts for most newborn deaths, and most of these deaths could be prevented with currently available, cost-effective interventions.” – ...
Mar 18, 2020
Infasurf® (calfactant) Business Continuity Statement: COVID-19
To Our Customers, It has become clear in the past few weeks we are facing an unprecedented challenge whose impact is being felt worldwide. We recogniz...
Jul 6, 2023
Over At ONY Biotech: Our Focus on Workplace Wellness
#OverAtONYBiotech, we understand that the strength of our company relies on the well-being and satisfaction of our employees. Workplace wellness is an...
Jun 28, 2018
Just Chillin’
Summer is in full swing here in Buffalo and wherever there is hot weather, ice cream is not far behind. While we work hard day in and day out at ONY B...
Jun 16, 2025
AerVia® Neonatal Supraglottic Airway: Now Commercially Available
ONY Biotech is pleased to announce the commercial availability of AerVia®, the first and only supraglottic airway device specifically designed for neo...
Apr 24, 2025
Introducing AerVia® Neonatal Supraglottic Airway
We are proud to announce the launch of AerVia®, a next generation supraglottic airway device designed specifically for neonates. Whether in the delive...
Feb 17, 2025
First Patient Enrolled in Aero-05 Study: Evaluating InfasurfAero™ for Non-Invasive Surfactant Delivery in Preterm Newborns
ONY Biotech is excited to announce that the first patient has been enrolled in the Aero-05 clinical study, marking a significant milestone in the eval...
Jul 26, 2023
Post-hoc Analysis of AERO-02 Trial Completed
Analysis results are in: nebulized calfactant reduced the need for instilled liquid surfactant by 50% in infants with clinical RDS born at 28-36 weeks...
Nov 3, 2020
Study Results are in on a Potential Non-Invasive Treatment for RDS
Study Results are in on a Potential Non-Invasive Treatment for RDS, the Leading Cause of Death in Premature Babies Has the potential to reduce intubat...
Feb 26, 2019
Leading the Way in Neonatal Therapies
Buffalo Business First speaks to ONY Biotech about the company’s continued strides toward creating innovative therapies to improve outcomes for ...